Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Statement of investor complaints- NSE and BSE-October 20,2017
October 20, 2017
Intimation to Stock exchange – NSE- Reply letter – Final application-Preferential allotment-October 10,2017
October 10, 2017
Intimation to Stock exchange – NSE-waiver of penalty – Non –submission of Financial results – October 10,2017
October 10, 2017
Intimation to Stock exchange – BSE-waiver of penalty – Non –submission of Financial results – October 06,2017
October 6, 2017
Corporate governance report -Quarter ended-September 30,2017-BSE
September 30, 2017
Reply letter - BSE- Non-submission of financial results -September 27,2017
September 27, 2017
Reply letter - NSE- Non-submission of financial results -September 27,2017
September 27, 2017
Intimation to BSE - Postponement of Creditors meeting -September 25,2017
September 25, 2017
Intimation to NSE - Postponement of Creditors meeting -September 25,2017
September 25, 2017
Intimation to NSE - Establishment Inspection Report from USFDA-September 21,2017
September 21, 2017
Intimation to BSE - Establishment Inspection Report from USFDA-September 21,2017
September 21, 2017
Intimation to BSE- Committee of Creditors meeting -September 21,2017
September 21, 2017
Intimation to NSE- Committee of Creditors meeting -September 21,2017
September 21, 2017
Intimation to BSE –Voting results-24th AGM- Revised format-September 18,2017
September 18, 2017
Intimation to NSE –Voting results-24th AGM- Revised format-September 18,2017
September 18, 2017
Intimation to NSE / BSE-Regulation 34 of the SEBI (LODR) Regulations,2015
September 18, 2017
Previous
1
...
Next
32 / 36